This inventor holds 6 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 3 EPO patents. Top assignees: Genvivo, Inc., Epeius Biotechnologies Corporation. Active years: 2018-2022.
Company Filing History:
Years Active: 2018-2022
Title: John P Levy: Innovator in Gene Therapy
Introduction
John P Levy is a notable inventor based in Lake Elsinore, CA (US). He has made significant contributions to the field of gene therapy, holding a total of 6 patents. His work primarily focuses on the development of improved Herpes Simplex Virus Thymidine Kinases, which have important applications in both diagnostics and therapeutics.
Latest Patents
Among his latest patents, Levy has developed nucleic acid sequences encoding improved Herpes Simplex Virus Thymidine Kinases. These innovations include their use in diagnostic and therapeutic applications. The thymidine kinases can be mutated using conservative mutations, non-conservative mutations, or both. Additionally, he has provided gene therapeutic systems, which include viral and retroviral particles. Another significant patent is the thymidine kinase diagnostic assay for gene therapy applications, which also features similar advancements in nucleic acid sequences and therapeutic systems.
Career Highlights
Throughout his career, John P Levy has worked with several companies, including Genvivo, Inc. and Epeius Biotechnologies Corporation. His expertise in gene therapy has positioned him as a key player in the biotechnology sector.
Collaborations
Levy has collaborated with notable professionals in his field, including Rebecca A Reed and Joseph McNulty. These partnerships have further enhanced his research and development efforts.
Conclusion
John P Levy's contributions to gene therapy and his innovative patents underscore his importance in the biotechnology industry. His work continues to pave the way for advancements in therapeutic applications.